Jump to main content
Jump to site search

Issue 2, 2017
Previous Article Next Article

Structure–activity relationship of novel macrocyclic biased apelin receptor agonists

Author affiliations

Abstract

Apelin is the endogenous ligand for the G protein-coupled receptor APJ and exerts a key role in regulating cardiovascular functions. We report herein a novel series of macrocyclic analogues of apelin-13 in which the N- and C-terminal residues as well as the macrocycle composition were chemically modified to modulate structure–activity relationships on the APJ receptor. To this end, the binding affinity and the ability to engage G protein-dependent and G protein-independent signalling pathways of the resulting analogues were assessed. In this series, the position and the nature of the C-terminal aromatic residue is a determinant for APJ interaction and β-arrestin recruitment, as previously demonstrated for linear apelin-13 derivatives. We finally discovered compounds 1, 4, 11 and 15, four potent G protein-biased apelin receptor agonists exhibiting affinity in the nanomolar range for APJ. These macrocyclic compounds represent very useful pharmacological tools to explore the therapeutic potential of the apelinergic system.

Graphical abstract: Structure–activity relationship of novel macrocyclic biased apelin receptor agonists

Back to tab navigation

Supplementary files

Publication details

The article was received on 14 Oct 2016, accepted on 29 Nov 2016 and first published on 29 Nov 2016


Article type: Paper
DOI: 10.1039/C6OB02247B
Citation: Org. Biomol. Chem., 2017,15, 449-458
  •   Request permissions

    Structure–activity relationship of novel macrocyclic biased apelin receptor agonists

    A. Murza, X. Sainsily, J. Côté, L. Bruneau-Cossette, É. Besserer-Offroy, J. Longpré, R. Leduc, R. Dumaine, O. Lesur, M. Auger-Messier, P. Sarret and É. Marsault, Org. Biomol. Chem., 2017, 15, 449
    DOI: 10.1039/C6OB02247B

Search articles by author

Spotlight

Advertisements